Imatinib Completed Phase 2 Trials for Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01153750Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct